日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ferroptosis in cancer toward molecular insights and clinical translation in pancreatic cancer

铁死亡在癌症中的分子机制研究及胰腺癌临床转化中的应用

Chen, Qun; Liu, Fengyuan; Zhang, Yufeng; Yan, Lingtao; Wu, Yang; Xu, Dong; Wu, Pengfei; Yuan, Hao; Jiang, Kuirong

Liquid Biopsy in Early Screening of Cancers: Emerging Technologies and New Prospects

液体活检在癌症早期筛查中的应用:新兴技术和新前景

Zhu, Hanyu; Li, Zhenyu; Xie, Kunxin; Kassim, Sajjaad Hassan; Cao, Cheng; Huang, Keyu; Lu, Zipeng; Ma, Chenshan; Li, Ying; Jiang, Kuirong; Yin, Lingdi

Post-surgery weight changes in pancreatic cancer: a prospective study on factors and survival impact

胰腺癌术后体重变化:一项关于影响因素和生存影响的前瞻性研究

Cui, Lei; Zhang, Liping; Yu, Huiping; Sun, Qingmei; Jiang, Kuirong; Wei, Jishu; Fang, Xiaoping

First-line nanoparticle polymeric micellar paclitaxel with gemcitabine in metastatic pancreatic cancer: a single-arm, prospective, and exploratory study

一线纳米颗粒聚合物胶束紫杉醇联合吉西他滨治疗转移性胰腺癌:一项单臂、前瞻性、探索性研究

Pang, Yuyang; Yu, Yehua; Zhang, Zhaoli; Lu, Wei; Shi, Jun; Lyu, Nan; Wang, Qianqian; Jiang, Kuirong; Xu, Dong; Wu, Yang; Zhang, Kai; Wei, Jishu; Chen, Jianmin; Guo, Feng; Lu, Zipeng; Xiao, Bin; Chen, Guosheng; Wu, Junli; Gao, Wentao; Wang, Yuqi; Wang, Fufeng; Tu, Min

Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials

glecirasib治疗KRAS G12C突变实体瘤的疗效和安全性:两项I/II期试验的汇总分析

Li, Jian; Deng, Ting; Gu, Yanhong; Calles Blanco, Antonio; Li, Zhihua; Bai, Chunmei; Wu, Lin; Huang, Jing; Li, Xingya; Yao, Yu; Song, Zhengbo; Li, Yongsheng; Liu, Lian; Xing, Ligang; Wu, Wenming; Martínez-Pérez, Julia; Hubert, Ayala; Zugazagoitia, Jon; Zhang, Jian; Wang, Yongsheng; Zhao, Yanqiu; Wen, Guilan; Xia, Guohao; Zhong, Diansheng; Chen, Xueqin; Jiang, Kuirong; Wang-Gillam, Andrea; Ding, Yuli; Liu, Sumei; Rao, Zhiyue; Liu, Xinghu; Shen, Lin

USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer.

USP19 通过去泛素化 NEK9 抑制 mTOR 通路,从而增强胰腺癌细胞的自噬性细胞死亡

Wang Guangfu, Dai Shangnan, Chen Jin, Zhang Kai, Huang Chenyu, Zhang Jinfan, Xie Kunxin, Lin Fuye, Wang Huijuan, Gao Yong, Yin Lingdi, Jiang Kuirong, Miao Yi, Lu Zipeng

Shared HLA-Bound Neoepitopes Are New Targets for Pancreatic Cancer Immunotherapy

共享的HLA结合新表位是胰腺癌免疫治疗的新靶点

Yuan, Hao; Chen, Qun; Jiang, Kuirong; Houchen, Courtney W; Zhang, Yuqing; Li, Min

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters

胰腺癌综合预处理分层系统:结合解剖可切除性和肿瘤生物学参数

Gao, Song; Liang, Yuexiang; Yu, Jun; Chang, Shaofei; Wang, Hongwei; Zhao, Tiansuo; Wang, Xiuchao; Man, Quan; Li, Zhifei; Zou, Yiping; Jiang, Kuirong; Gao, Chuntao; Hao, Jihui

ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network

ALDH1A3 通过 AP-1/RUNX2 增强子网络促进侵袭性基底样胰腺癌的发生发展。

Zou, Xiaoping; Nie, Shuang; Cao, Jing; Shi, Mengyue; Schuck, Kathleen; Shi, Zhao; Zhang, Lingling; Li, Hongzhen; Sun, Yifeng; Fang, Chao; Hu, Jingxiong; Niu, Yiqi; Yu, Yuanyuan; Zhang, Zhiheng; Li, Chao; Hu, Mingyue; Wang, Lei; Jiang, Kuirong; Lu, Zipeng; Akkan, Jan; Raulefs, Susanne; Kahlert, Christoph; Roth, Susanne; Herr, Ingrid; Wan, Yuan; Mihaljevic, Andre; Qian, Xuetian; Zhang, Qi; Wang, Maggie Haitian; Kleeff, Jörg; Friess, Helmut; Gu, Zuguang; Michalski, Christoph W; Shen, Shanshan; Kong, Bo

The feasibility and potential benefits of administering adjuvant chemotherapy in resected pancreatic cancer patients unable to promptly remove intraperitoneal drainage post-surgery: a retrospective cohort study

术后无法及时移除腹腔引流管的胰腺癌切除患者接受辅助化疗的可行性及潜在获益:一项回顾性队列研究

Xu, Dong; Lv, Nan; Wang, Qianqian; Wu, Yang; Zhang, Kai; Miao, Yi; Wei, Jishu; Tu, Min; Jiang, Kuirong